Indication
Large-cell Neuroendocrine Carcinoma
1 clinical trial
1 product
Clinical trial
Phase II Study of Enasidenib in IDH2-mutated Malignant Sinonasal and Skull Base TumorsStatus: Recruiting, Estimated PCD: 2027-12-31
Product
Enasidenib1 clinical trial
1 product